A phase II study to assess the efficacy of osimertinib in patients with EGFR MT(+)T790M(-) NSCLC
Daisuke Hayakawa,Masayuki Takeda,Mototsugu Shimokawa,Atsushi Nakamura,Kaname Nosaki,Yasutaka Watanabe,Terufumi Kato,Hiroshi Tanaka,Toshiaki Takahashi,Masahide Oki,Motoko Tachihara,Daichi Fujimoto,Kakuhiro Yamaguchi,Hidetoshi Hayashi,Shoichiro Yamamoto,Eiji Iwama,Koichi Azuma,Nobuyuki Yamamoto,Kazuhiko Nakagawa ANNALS OF ONCOLOGY(2023)
AI 理解论文
溯源树
样例